Clinical Trials Logo

Clinical Trial Summary

This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).


Clinical Trial Description

This product is being tested for its ability to reduce lateral canthal lines (LCL), also known as Crow's Feet. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03912805
Study type Interventional
Source Eirion Therapeutics Inc.
Contact
Status Completed
Phase Phase 2
Start date February 27, 2019
Completion date October 4, 2019

See also
  Status Clinical Trial Phase
Completed NCT01951742 - Dose Finding Study In Subjects With Crow's Feet Phase 2
Completed NCT03326856 - ET-01 in Subjects With Lateral Canthal Lines Phase 2
Completed NCT03839693 - ET-01 in Subjects With Lateral Canthal Lines, LCL-208 Phase 2
Completed NCT00888914 - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Active, not recruiting NCT06021418 - Efficacy and Safety of DKB-119 in Patients in Crow's Feet N/A
Completed NCT01358695 - Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet Phase 2
Completed NCT01124565 - Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2
Completed NCT00968825 - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Recruiting NCT04818203 - A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet Phase 1/Phase 2
Active, not recruiting NCT04985916 - ET-01 in Subjects With Lateral Canthal Lines, LCL-210 Phase 2
Completed NCT01064518 - Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2
Completed NCT00968942 - Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines Phase 2
Completed NCT03655691 - ET-01 in Subjects With Lateral Canthal Lines, LCL-207 Phase 2
Completed NCT01124552 - A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults Phase 2